Muir Russell

434 total citations
10 papers, 342 citations indexed

About

Muir Russell is a scholar working on Physiology, Immunology and Infectious Diseases. According to data from OpenAlex, Muir Russell has authored 10 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 4 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in Muir Russell's work include Antifungal resistance and susceptibility (3 papers), Alzheimer's disease research and treatments (2 papers) and Computational Drug Discovery Methods (2 papers). Muir Russell is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Alzheimer's disease research and treatments (2 papers) and Computational Drug Discovery Methods (2 papers). Muir Russell collaborates with scholars based in United Kingdom, Sweden and United States. Muir Russell's co-authors include Alan R. Kugler, Robert Alexander, Susanna Eketjäll, Samantha Budd Haeberlein, David Han, Paul Norwood, Graham Blakey, J.A. Lockton, John Perrett and John Mo and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Neurobiology of Aging and Journal of Immunological Methods.

In The Last Decade

Muir Russell

10 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Muir Russell United Kingdom	8	127	96	76	71	61	10	342
Chia Hsin Ju United States	5	31 0.2×	56 0.6×	100 1.3×	31 0.4×	39 0.6×	8	332
Hirotoshi Kakuta Japan	14	44 0.3×	42 0.4×	221 2.9×	64 0.9×	17 0.3×	25	531
Rohini Ramakrishnan United States	8	51 0.4×	17 0.2×	98 1.3×	22 0.3×	45 0.7×	10	365
Jacqueline Marti-Jaun Switzerland	10	36 0.3×	85 0.9×	128 1.7×	14 0.2×	82 1.3×	15	463
Jonathan P. Etter United States	10	86 0.7×	29 0.3×	223 2.9×	17 0.2×	31 0.5×	12	473
Pascal Druzgala United States	11	58 0.5×	30 0.3×	106 1.4×	33 0.5×	13 0.2×	24	456
Mary Piotrowski United States	7	93 0.7×	70 0.7×	91 1.2×	70 1.0×	9 0.1×	8	355
Deborah Hilliard United States	5	113 0.9×	116 1.2×	107 1.4×	10 0.1×	15 0.2×	5	532
Johan Kolmert Sweden	12	100 0.8×	37 0.4×	242 3.2×	8 0.1×	60 1.0×	28	491
Benedetta Riccardi Italy	10	57 0.4×	22 0.2×	91 1.2×	16 0.2×	26 0.4×	24	294

Countries citing papers authored by Muir Russell

Since Specialization

Citations

This map shows the geographic impact of Muir Russell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muir Russell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muir Russell more than expected).

Fields of papers citing papers by Muir Russell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muir Russell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muir Russell. The network helps show where Muir Russell may publish in the future.

Co-authorship network of co-authors of Muir Russell

This figure shows the co-authorship network connecting the top 25 collaborators of Muir Russell. A scholar is included among the top collaborators of Muir Russell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muir Russell. Muir Russell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Nelander, Karin, Maria Lagerström‐Fermér, Erik Michaëlsson, et al.. (2020). Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction. Clinical and Translational Science. 14(3). 812–819. 25 indexed citations

Asimus, Sara, Robert S. Palmer, Muna Albayaty, et al.. (2020). Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid‐related orphan receptor γ agonist AZD0284. British Journal of Clinical Pharmacology. 86(7). 1398–1405. 9 indexed citations

Palmer, Robert S., Jukka Mäenpää, Alexandra Jauhiainen, et al.. (2018). Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure‐Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects. Clinical Pharmacology & Therapeutics. 104(6). 1155–1164. 76 indexed citations

Russell, Muir, et al.. (2017). Simple and robust two-step ex vivo whole blood stimulation assay suitable for investigating IL-17 pathway in a clinical laboratory setting. Journal of Immunological Methods. 454. 71–75. 2 indexed citations

Sakamoto, Kei, Shunji Matsuki, Kyoko Matsuguma, et al.. (2017). BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides. The Journal of Clinical Pharmacology. 57(11). 1460–1471. 50 indexed citations

Russell, Muir, Nina Prokoph, Neil Henderson, et al.. (2017). Determining myeloperoxidase activity and protein concentration in a single assay: Utility in biomarker and therapeutic studies. Journal of Immunological Methods. 449. 76–79. 6 indexed citations

Cebers, Gvido, Robert Alexander, Samantha Budd Haeberlein, et al.. (2016). AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease. Journal of Alzheimer s Disease. 55(3). 1039–1053. 68 indexed citations

Alexander, Robert, Samantha L. Budd, Muir Russell, et al.. (2014). AZD3293 A novel BACE1 inhibitor: safety, tolerability, and effects on plasma and CSF Aβ peptides following single- and multiple-dose administration. Neurobiology of Aging. 35. S2–S2. 20 indexed citations

Blakey, Graham, et al.. (2003). Pharmacokinetic and pharmacodynamic assessment of a five‐probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1. British Journal of Clinical Pharmacology. 57(2). 162–169. 58 indexed citations

10.

Srivastava, E D, et al.. (1991). Transdermal nicotine in active ulcerative colitis. European Journal of Gastroenterology & Hepatology. 3(11). 815–818. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact